Anthem Biosciences (ANTHEM) Share Price Falls 2% Today
- September 21, 2026
- Posted by: Harsh Piplani
- Category: News
Anthem Biosciences Share Price moved lower today, with the stock at Rs 915.05, down 2.00% from the previous close, and the company carrying a market capitalisation of Rs 52,619.43 crore. In Anthem Biosciences Share Price Today action, the price event is relevant because the supplied data confirms a clear one-day decline, but it does not establish a company-specific catalyst. The stock remains a Large Cap, and the move comes after a session that opened above the previous close and later settled near the day’s low. Univest tracks such stock news with a focus on verified market data, so this update stays to what is directly observable. For readers searching Anthem Biosciences Stock News or Anthem Biosciences Share Price Fall, the key takeaway is straightforward: price action has softened, while the wider financial picture and sector comparison still need to be read alongside today’s move.
Anthem Biosciences (ANTHEM) Share Price Today: Price Action Analysis
| Metric | Value |
|---|---|
| Current Price | Rs 915.05 |
| Previous Close | Rs 933.75 |
| Today's Move | -Rs 18.70 (-2%) |
| Open | Rs 940.9 |
| High | Rs 946.95 |
| Low | Rs 915 |
| Turnover | Rs 8.47 crore |
| Market Capitalisation | Rs 52,619.43 crore |
| Market Cap Category | Large Cap |
Anthem Biosciences Share Price Today reflects a decline of Rs 18.70 from the previous close of Rs 933.75 to Rs 915.05. The stock opened at Rs 940.90, moved to a day high of Rs 946.95, and touched a day low of Rs 915.00 before ending just above that level. The session range shows that the stock spent the day trading below the opening price and below the prior close. Turnover stood at Rs 8.47 crore, which is a factual traded-value figure and should be read as such, without drawing extra conclusions from it. The current market-cap category is Large Cap, and the market capitalisation is Rs 52,619.43 crore. For Anthem Biosciences Share Price News and Anthem Biosciences Share Price Update searches, today’s move is best understood as a measured share price decline rather than a broader narrative. Univest would frame this as a verified price action event that still requires fundamental and sector context.
The day’s movement also matters because the opening level was higher than both the previous close and the final price, showing that the stock was unable to hold those early levels through the session. That keeps Anthem Biosciences Share Price Today in focus for readers comparing opening price, intraday high, intraday low and closing price across the same trading day. With no company-specific catalyst supplied, the verified data confirms the fall but not the reason behind it. That makes the next layer of analysis important, especially when looking at the company’s valuation, profitability and position within healthcare stock news. The question for investors is not only what moved today, but what the underlying numbers say about Anthem Biosciences Share Price relative to peers and the broader pharmaceuticals universe.
Anthem Biosciences (ANTHEM) Fundamental Analysis
| Metric | Value |
|---|---|
| Market Capitalisation | Rs 52,619.43 crore |
| P/E Ratio | 91.36x |
| P/B Ratio | 16.81x |
| ROE | 21.98% |
| ROCE | 29.62% |
| EPS | Rs 10.22 |
| Book Value Per Share | Rs 55.53 |
| Dividend Yield | 0.21% |
The company’s P/E of 91.36 and P/B of 16.81 are important because they indicate that the market is assigning a sizeable multiple to current earnings and net asset value. That does not tell us why the share price fell today, but it does show that the price action is happening in a stock already valued well above the median for its industry. ROE at 21.98% and ROCE at 29.62% are stronger than the medians in the sector benchmark, while EPS at Rs 10.22 and book value at Rs 55.53 provide the per-share profit and accounting base behind the stock. Dividend yield of 0.21% is a factual historical payout measure, not a forecast. For Anthem Biosciences Share Price News readers, the fundamental analysis suggests a company with premium valuation and solid return ratios, which is a useful context for today’s share price fall.
Sector and Industry Context
| Metric | Value |
|---|---|
| Sector | Healthcare |
| Industry | Pharmaceuticals & Drugs |
| Benchmark Scope | same industry |
| Company P/E Ratio | 91.36x |
| Benchmark Median P/E | 32.87x |
| Benchmark Average P/E | 48.77x |
| Benchmark P/E Range | 3.4x to 683.5x |
| Company P/B Ratio | 16.81x |
| Benchmark Median P/B | 3.08x |
| Benchmark Average P/B | 4.31x |
| Company ROE | 21.98% |
| Benchmark Median ROE | 11.7% |
| Benchmark Average ROE | 10.25% |
| Company ROCE | 29.62% |
| Benchmark Median ROCE | 13.46% |
| Benchmark Average ROCE | 12.93% |
| Company Market Capitalisation | Rs 52,619.43 crore |
| Benchmark Median Market Cap | Rs 701.78 crore |
| Benchmark Average Market Cap | Rs 13,926.75 crore |
Anthem Biosciences operates in Healthcare and the Pharmaceuticals & Drugs industry, and the supplied benchmark compares it with 204 companies in the same industry. Within that group, Anthem Biosciences Share Price is set against a company P/E of 91.36 versus a benchmark median of 32.87 and average of 48.77. Its P/B of 16.81 is also well above the benchmark median of 3.08 and average of 4.31. On profitability, ROE at 21.98% stands above the benchmark median of 11.7%, while ROCE at 29.62% is above the benchmark median of 13.46%. The market-cap median in the industry is Rs 701.78 crore, while the average is Rs 13,926.75 crore, placing Anthem Biosciences in a much larger company bracket than the typical peer in the benchmark set.
This sector analysis is central to Anthem Biosciences Share Price Today because it shows that the stock’s valuation is higher than the industry’s central tendency, while its return ratios are also stronger than the benchmark medians. The benchmark scope is the same industry, and the comparison uses 204 companies, which gives useful context for healthcare stock news and share price fall searches. Anthem Biosciences Share Price News therefore sits at the intersection of a strong-return profile and a premium multiple. That combination does not explain today’s fall, but it does explain why the stock attracts attention in valuation-aware stock analysis. Univest uses this kind of sector lens to separate the one-day move from the broader industry backdrop.
Peer Comparison
| Company | Symbol | Market Cap (Cr) | P/E | P/B | ROE (%) | ROCE (%) |
|---|---|---|---|---|---|---|
| Sun Pharmaceutical Industries | SUNPHARMA | 4,40,397.93 | 36.41 | 5.09 | 14.85 | 19.11 |
| Divi's Laboratories | DIVISLAB | 2,48,664.42 | 85.01 | 14.08 | 16.19 | 21.51 |
| Torrent Pharmaceuticals | TORNTPHARM | 1,82,738.23 | 83.79 | 20.36 | 26.76 | 19.27 |
| Zydus Lifesciences | ZYDUSLIFE | 1,15,012.19 | 25.48 | 4.27 | 19.69 | 21.39 |
| Cipla | CIPLA | 1,10,793.75 | 32.87 | 3.15 | 11.83 | 16 |
Among the supplied peers, Anthem Biosciences Share Price can be read against a wide range of healthcare valuations and return profiles. Its P/E of 91.36 is above Sun Pharmaceutical Industries at 36.41, Cipla at 32.87 and Zydus Lifesciences at 25.48, and close to Divi’s Laboratories at 85.01 and Torrent Pharmaceuticals at 83.79. On ROE, Anthem Biosciences at 21.98% sits above Sun Pharma, Divi’s, Zydus Lifesciences and Cipla, but below Torrent Pharmaceuticals and Lupin, which shows a mixed relative picture rather than a single dominant comparison.
Its ROCE of 29.62% is higher than all five peers in this set, including Lupin at 28.86% and Torrent Pharmaceuticals at 19.27%. Market capitalisation at Rs 52,619.43 crore is smaller than the larger listed peers such as Sun Pharma, Divi’s and Torrent Pharmaceuticals, but above Cipla, Aurobindo Pharma and Lupin in the broader list supplied. For Anthem Biosciences Share Price Today, the peer data suggests a company with strong return ratios and a premium valuation. Univest readers tracking Anthem Biosciences Stock News often use this sort of peer comparison to understand whether today’s share price fall changes the relative picture or simply alters the short-term price path.
Why Investors Are Watching Anthem Biosciences
- Anthem Biosciences Share Price fell 2.00% today, moving from Rs 933.75 to Rs 915.05.
- The stock opened at Rs 940.90, made a day high of Rs 946.95 and a day low of Rs 915.00.
- Market capitalisation stands at Rs 52,619.43 crore, and the company is classified as Large Cap.
- P/E is 91.36, P/B is 16.81, ROE is 21.98% and ROCE is 29.62%.
- In the industry benchmark, the company’s P/E, P/B, ROE and ROCE are all above the median values supplied.
About Anthem Biosciences
Anthem Biosciences is classified in Healthcare and the Pharmaceuticals & Drugs industry. The supplied data places the company within a large listed pharmaceutical peer set and provides the market context through industry benchmark comparisons. For readers following Anthem Biosciences Share Price, this is the relevant company background available from the verified dataset. Univest presents the stock through its exchange-linked market context, sector classification and financial metrics so that the day’s share price fall can be read alongside the company’s listed identity and sector placement.
Track Anthem Biosciences Share Price on Univest
Use Anthem Biosciences (ANTHEM) live share-price page,Univest top decliners screener,Univest market blogs to review live stock data, top decliners and related market analysis.
Readers can track Anthem Biosciences Share Price on Univest for live price updates, share price history, fundamental ratios, shareholding pattern, 52-week levels and market insights. Univest also brings together stock news, sector context and company data in one place, making it easier to review Anthem Biosciences Share Price Today after a sharp session move.
Disclaimer: Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
Why did Anthem Biosciences Share Price fall today?
Ans. The supplied data confirms that Anthem Biosciences Share Price fell 2.00% today, but it does not establish a company-specific catalyst. The stock closed at Rs 915.05 after opening at Rs 940.90.
What is Anthem Biosciences Share Price today?
Ans. Anthem Biosciences Share Price today is Rs 915.05. That compares with the previous close of Rs 933.75, showing a decline of Rs 18.70 during the session. The previous close was Rs 933.75.
What is the market capitalisation of Anthem Biosciences?
Ans. Anthem Biosciences has a market capitalisation of Rs 52,619.43 crore. The company is classified as a Large Cap in the supplied data. The company operates in the Healthcare sector. Its P/E ratio is 91.36x.
How does Anthem Biosciences compare on valuation?
Ans. Anthem Biosciences Share Price is supported by a P/E of 91.36 and a P/B of 16.81. Both are above the industry medians supplied for the same industry benchmark. The company trades at a P/E ratio of 91.36x.
How strong are the return ratios for Anthem Biosciences?
Ans. Anthem Biosciences reports ROE of 21.98% and ROCE of 29.62%. Both are above the industry benchmark medians, which gives useful context for the stock’s premium valuation. ROE stands at 21.98%.
What do EPS and book value show for Anthem Biosciences?
Ans. EPS is Rs 10.22 and book value is Rs 55.53. EPS shows earnings attributable to each share, while book value per share reflects the accounting net worth behind each share.
Is Anthem Biosciences a high-yield dividend stock?
Ans. Anthem Biosciences has a dividend yield of 0.21%. That is a factual payout measure from the supplied data and should be read as historical context, not as a future payout promise.
